Fund Holdings — SR ONE CAPITAL MANAGEMENT, LP

Total Portfolio Value
$364.09M
Total Bought
$109.33M
Total Sold
$11.43M
Net Transaction
+$97.90M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
CRISPR THERAPEUTICS AG(CRSP)01,048,951+1,048,951071,49719.64%+71,497
NKARTA INC(NKTX)1,333,3333,333,333+2,000,0008,80036,0339.90%+27,233
ARS PHARMACEUTICALS INC(SPRY)4,012,9034,012,903021,99141,01211.26%+19,021
MINERALYS THERAPEUTICS INC(MLYS)1,794,6002,016,822+222,22215,43426,0377.15%+10,604
DESIGN THERAPEUTICS INC(DSGN)6,526,4766,526,476017,29526,3027.22%+9,007
ARCELLX INC
COMMON STOCK
3,146,6302,346,630-800,000174,638163,20844.83%-11,430
Page 1 of 1
SR ONE CAPITAL MANAGEMENT, LP — 13F Holdings — Q1 2024 | TickerTrail